Arcus Biosciences Stock Technical Analysis
| RCUS Stock | USD 9.15 0.27 2.87% |
As of the 20th of July, Arcus Biosciences shows the risk adjusted performance of 0.0903, and Mean Deviation of 2.94. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Arcus Biosciences, as well as the relationship between them. Please confirm Arcus Biosciences mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if Arcus Biosciences is priced correctly, providing market reflects its regular price of 9.15 per share. Given that Arcus Biosciences has jensen alpha of 0.1025, we suggest you to validate Arcus Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.
Arcus Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Arcus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ArcusArcus Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Arcus Biosciences Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 28.18 | Strong Buy | 13 | Odds |
Most Arcus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Arcus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Arcus Biosciences, talking to its executives and customers, or listening to Arcus conference calls.
Arcus Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Arcus Biosciences Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Arcus Biosciences across different markets.
Arcus Biosciences Trend Analysis
Use this graph to draw trend lines for Arcus Biosciences. You can use it to identify possible trend reversals for Arcus Biosciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Arcus Biosciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Arcus Biosciences Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Arcus Biosciences applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Arcus Biosciences will continue generating value for investors. It has 122 observation points and a regression sum of squares at 3.44, which is the sum of squared deviations for the predicted Arcus Biosciences price change compared to its average price change.About Arcus Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Arcus Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Arcus Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Arcus Biosciences price pattern first instead of the macroeconomic environment surrounding Arcus Biosciences. By analyzing Arcus Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Arcus Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Arcus Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 140.13 | 131.03 | 35.37 | 33.6 | PTB Ratio | 2.27 | 3.06 | 2.77 | 3.36 |
Arcus Biosciences July 20, 2025 Technical Indicators
Most technical analysis of Arcus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Arcus from various momentum indicators to cycle indicators. When you analyze Arcus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0903 | |||
| Market Risk Adjusted Performance | 0.2006 | |||
| Mean Deviation | 2.94 | |||
| Semi Deviation | 3.42 | |||
| Downside Deviation | 3.76 | |||
| Coefficient Of Variation | 1128.05 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.44 | |||
| Information Ratio | 0.0516 | |||
| Jensen Alpha | 0.1025 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | 0.0522 | |||
| Treynor Ratio | 0.1906 | |||
| Maximum Drawdown | 18.17 | |||
| Value At Risk | (6.42) | |||
| Potential Upside | 6.49 | |||
| Downside Variance | 14.13 | |||
| Semi Variance | 11.71 | |||
| Expected Short fall | (3.09) | |||
| Skewness | (0.07) | |||
| Kurtosis | 0.5574 |
Arcus Biosciences July 20, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Arcus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | (0.57) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 9.37 | ||
| Day Typical Price | 9.29 | ||
| Price Action Indicator | (0.35) | ||
| Market Facilitation Index | 0.47 |
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.